Advanced search

Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), p. 85.

(1992) In EUROPEAN HEART JOURNAL 13(suppl.). p.85-85
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Delanghe, Joris, Daniel Duprez, Marc De Buyzere, B Bergez, Geert Leroux-Roels, and Denis Clement. 1992. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), P. 85.” In , 13:85–85.
APA
Delanghe, Joris, Duprez, D., De Buyzere, M., Bergez, B., Leroux-Roels, G., & Clement, D. (1992). Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), p. 85. (Vol. 13, pp. 85–85). Presented at the 14th Congress of the European Society of Cardiology.
Vancouver
1.
Delanghe J, Duprez D, De Buyzere M, Bergez B, Leroux-Roels G, Clement D. Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), p. 85. 1992. p. 85–85.
MLA
Delanghe, Joris, Daniel Duprez, Marc De Buyzere, et al. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), P. 85.” Vol. 13. 1992. 85–85. Print.
@inproceedings{224603,
  author       = {Delanghe, Joris and Duprez, Daniel and De Buyzere, Marc and Bergez, B and Leroux-Roels, Geert and Clement, Denis},
  language     = {eng},
  location     = {Barcelona, Spain},
  number       = {suppl.},
  pages        = {85--85},
  title        = {Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. Eur. Heart J., 1992, 13 (Abstract Supplement), p. 85.},
  volume       = {13},
  year         = {1992},
}